SYNLAB.com | Home Page | High Value Tests | Contact Results Business Laboratories SYNLAB's core values are grounded in the perfect balance between strong medical culture and overall management competencies. SYNLAB European Leader SYNLAB in Spain and Portugal Expanding Company SYNLAB in Figures Contact SYNLAB European Leader SYNLAB Activity Mission, vision and values History Quality Home > SYNLAB European Leader SYNLAB European Leader The new SYNLAB Group , formed by the union of LABCO and Synlab , is the undisputed leader in human medicine laboratory services on the European market. SYNLAB offers a full range of medical laboratory services for physicians, clinics, and the pharmaceutical industry. High Value Tests See all Septina9 Colon cancer early detection in blood Read more neoBona The new generation of non-invasive prenatal test Read more ADGen Genetic evaluation of predisposition to Alzheimer's disease Read more BRCA + 16GENES Hereditary gynecological cancer prevention Read more NutriHealth Advanced nutrigenetic analysis Read more COLONPLUS Hereditary gastrointestinal cancer prevention Read more preconGEN Genetic test for the study of carriers by NGS Read more ISAC test Evaluation of IgE against 112 allergenic proteins Read more Blog See all posts Beyond the spring allergy 06/02/2017 Read more Half of the people with Glaucoma are unaware of it. 03/13/2017 Read more 5 tips to take care of your heart this Christmas 12/21/2016 Read more Tips to prevent the flu 11/04/2016 Read more Contact us | Site Map | Privacy Policy | Recommend Site | Add to favorites Back to the start Copyright © 2011-2017 SYNLAB. All rights reserved Follow us on:

SYNLAB.com | Home Page | High Value Tests | Contact Results Business Laboratories The new generation of non-invasive prenatal testing SYNLAB European Leader SYNLAB in Spain and Portugal Expanding Company SYNLAB in Figures Contact Home Page > High Value Tests > neoBona select your analysis neoBona neoBona is the new generation of non-invasive prenatal test resulting from the combined expertise of SYNLAB, one of the European leaders in prenatal diagnostics, and Illumina, one of the world leaders in DNA sequencing. Detects the most common chromosomal abnormalities in pregnancy through the study of the free DNA of the fetus present in maternal blood. NEOBONA CHROMOSOMAL ALTERATIONS SCIENTIFIC BASIS ADVANTAGE INDICATIONS REQUIREMENTS Go to the store More information Downloads Share Chromosomal abnormalities, such as trisomy 21 (Down syndrome), are present in 1-2% of fetuses. There is a wide range of tests available to evaluate the correct development of the future baby before its birth. SYNLAB is a pioneer in molecular prenatal diagnosis thanks to the incorporation of new scientific advances to offer a next-generation non-invasive prenatal test, backed by the experience and ability of one of the leading European laboratories. Contact us | Site Map | Privacy Policy | Recommend Site | Add to favorites Back to the start Copyright © 2011-2017 SYNLAB. All rights reserved Follow us on: